Literature DB >> 22821477

Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.

Javier Iglesias-González1, Sofía Sánchez-Iglesias, Estefanía Méndez-Álvarez, Sarah Rose, Atsuko Hikima, Peter Jenner, Ramón Soto-Otero.   

Abstract

Oxidative stress and mitochondrial dysfunction are two pathophysiological factors often associated with the neurodegenerative process involved in Parkinson's disease (PD). Although, 6-hydroxydopamine (6-OHDA) is able to cause dopaminergic neurodegeneration in experimental models of PD by an oxidative stress-mediated process, the underlying molecular mechanism remains unclear. It has been established that some antioxidant enzymes such as catalase (CAT) and superoxide dismutase (SOD) are often altered in PD, which suggests a potential role of these enzymes in the onset and/or development of this multifactorial syndrome. In this study we have used high-resolution respirometry to evaluate the effect of 6-OHDA on mitochondrial respiration of isolated rat brain mitochondria and the lactate dehydrogenase cytotoxicity assay to assess the percentage of cell death induced by 6-OHDA in human neuroblastoma cell line SH-SY5Y. Our results show that 6-OHDA affects mitochondrial respiration by causing a reduction in both respiratory control ratio (IC(50) = 200 ± 15 nM) and state 3 respiration (IC(50) = 192 ± 17 nM), with no significant effects on state 4(o). An inhibition in the activity of both complex I and V was also observed. 6-OHDA also caused cellular death in human neuroblastoma SH-SY5Y cells (IC(50) = 100 ± 9 μM). Both SOD and CAT have been shown to protect against the toxic effects caused by 6-OHDA on mitochondrial respiration. However, whereas SOD protects against 6-OHDA-induced cellular death, CAT enhances its cytotoxicity. The here reported data suggest that both superoxide anion and hydroperoxyl radical could account for 6-OHDA toxicity. Furthermore, factors reducing the rate of 6-OHDA autoxidation to its p-quinone appear to enhance its cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821477     DOI: 10.1007/s11064-012-0838-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  59 in total

1.  p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.

Authors:  Yasuhiko Izumi; Hideyuki Sawada; Noriko Sakka; Noriyuki Yamamoto; Toshiaki Kume; Hiroshi Katsuki; Shun Shimohama; Akinori Akaike
Journal:  J Neurosci Res       Date:  2005-03-15       Impact factor: 4.164

2.  Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra.

Authors:  M J Marti; C J James; T F Oo; W J Kelly; R E Burke
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

3.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

4.  Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease.

Authors:  Subhas C Biswas; Elizabeth Ryu; Clara Park; Cristina Malagelada; Lloyd A Greene
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

Review 5.  Role of mitochondria in oxidative stress and aging.

Authors:  Giorgio Lenaz; Carla Bovina; Marilena D'Aurelio; Romana Fato; Gabriella Formiggini; Maria Luisa Genova; Giovanni Giuliano; Milena Merlo Pich; Ugo Paolucci; Giovanna Parenti Castelli; Barbara Ventura
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

6.  6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate.

Authors:  R E Heikkila; G Cohen
Journal:  Science       Date:  1973-08-03       Impact factor: 47.728

7.  Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine.

Authors:  Y Glinka; K F Tipton; M B Youdim
Journal:  Eur J Pharmacol       Date:  1998-06-12       Impact factor: 4.432

8.  Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line.

Authors:  E Tiffany-Castiglioni; R P Saneto; P H Proctor; J R Perez-Polo
Journal:  Biochem Pharmacol       Date:  1982-01-15       Impact factor: 5.858

Review 9.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

10.  Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.

Authors:  J F Turrens; A Boveris
Journal:  Biochem J       Date:  1980-11-01       Impact factor: 3.857

View more
  19 in total

1.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

2.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

3.  Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.

Authors:  Kai Lun Chang; Ling Rong Wong; Hai Ning Pee; Shili Yang; Paul Chi-Lui Ho
Journal:  Mol Neurobiol       Date:  2019-04-23       Impact factor: 5.590

Review 4.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

Review 5.  Parkinson's disease: experimental models and reality.

Authors:  Peizhou Jiang; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2017-11-18       Impact factor: 17.088

6.  6-Hydroxydopamine: a far from simple neurotoxin.

Authors:  Damir Varešlija; Keith F Tipton; Gavin P Davey; Andrew G McDonald
Journal:  J Neural Transm (Vienna)       Date:  2020-01-01       Impact factor: 3.575

7.  Zhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease rats.

Authors:  Qingwei Zhou; Jiajun Chen; Shihong Yi; Yongwei Lou; Weimin Tang; Yongmao Liu; Pengguo Zhang
Journal:  Neural Regen Res       Date:  2012-09-25       Impact factor: 5.135

8.  Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.

Authors:  Rita Valenzuela; Maria A Costa-Besada; Javier Iglesias-Gonzalez; Emma Perez-Costas; Begoña Villar-Cheda; Pablo Garrido-Gil; Miguel Melendez-Ferro; Ramon Soto-Otero; Jose L Lanciego; Daniel Henrion; Rafael Franco; Jose L Labandeira-Garcia
Journal:  Cell Death Dis       Date:  2016-10-20       Impact factor: 8.469

9.  Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.

Authors:  Andrea Tarozzi; Fabiana Morroni; Cecilia Bolondi; Giulia Sita; Patrizia Hrelia; Alice Djemil; Giorgio Cantelli-Forti
Journal:  Int J Mol Sci       Date:  2012-08-30       Impact factor: 6.208

10.  Pax6 influences expression patterns of genes involved in neuro- degeneration.

Authors:  Suman Mishra; Shashank Kumar Maurya; Khushboo Srivastava; Sachin Shukla; Rajnikant Mishra
Journal:  Ann Neurosci       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.